ALLIED CORP - ALID STOCK NEWS

Allied Corp (OTCQB: ALID) has signed a forward purchase agreement with a Sao Paulo-based specialty medical care hospital, initiating a purchase of $147,000 worth of products for oncology patients. The agreement, which took four months for approval, underscores Allied's growing market presence in Brazil's healthcare sector. The first shipment is scheduled for May 2022, with ongoing monthly purchases anticipated. CEO Calum Hughes highlighted the significance of this deal in driving revenue and enhancing shareholder value.

Allied Corp (OTCQB: ALID) has announced the initiation of three significant commercial exports of Colombian-produced dried cannabis flower, totaling 2,500 kilograms. These exports include shipments to Australia and two to the United States, aligning with recent regulatory approvals. This milestone follows a monthly supply agreement for 1,000 kilograms of cannabis flower for a U.S. operator, leveraging Colombia's newfound export regulations. CEO Calum Hughes emphasized the achievement as a result of years of strategic relationship building and production excellence.

Allied Corp (OTCQB: ALID) announced the final approval of Colombian Regulation 227, allowing for the export of cannabis flower. Following President Ivan Duque's July 2021 decree lifting the export prohibition, Allied is set to begin international shipments of dried cannabis flower, targeting markets where it's legal. The company's CEO, Calum Hughes, highlighted the growth potential in the cannabis sector, particularly for dried flower. Allied has previously exported cannabis derivatives and is preparing for multiple export requests.

Allied Corp (OTCQB: ALID) has filed for a full patent on innovative dosing regimens for pharmaceutical and nutraceutical mushroom and cannabis compositions aimed at treating CNS disorders and enhancing mental health. The patent, stemming from a provisional filing in March 2021, prioritizes Allied's claims over later submissions. The formulation, branded as Psilonex™, combines psilocybin and CBD, claiming a synergistic effect in treatment. The company is actively pursuing clinical research to validate these treatments for mental health issues, particularly for veterans and first responders.

Allied Corp (OTCQB: ALID) has completed a successful transaction, shipping 10 kilograms of CBD isolate from Colombia to Australia, marking a re-order under a recurring sales contract. The order was divided into 100 bottles for distribution across 100 pharmacies in Australia. CEO Calum Hughes stated that the company is committed to fulfilling existing contracts and strengthening its trade routes in anticipation of future shipping of Colombian cannabis flower. Allied Corp is positioning itself as a leader in medical cannabis with plans for product expansion.

Allied Corp (OTCQB: ALID) announces its platinum sponsorship of the Tactical Games to support veterans and athletes. This partnership will provide Allied's Tactical Relief™ products at events across multiple U.S. locations in 2022, aimed at enhancing tactical skills. Allied's brand ambassadors will engage with participants and attendees, promoting awareness of its offerings. The Tactical Games blend marksmanship, fitness, and tactics, emphasizing the importance of efficiency under stress, aligning with the company’s mission to serve the veteran community.

Allied Corp (OTCQB: ALID) has praised the Colombian Government's recent passing of Regulation 227, which allows for the export of cannabis flower. This regulation, effective February 20, 2022, follows previous moves to lift export restrictions on dried cannabis. Allied has been preparing for this opportunity, holding contracts and import approvals ready to activate. The global cannabis flower market is rapidly growing, and Allied aims to capitalize on this by exporting dried cannabis internationally, with further guidelines expected soon from Colombia.

Allied Corp (OTCQB: ALID) has signed a significant forward purchase agreement with an Australian pharmaceutical partner to supply 1,000 kg of cannabis flower for €1 million. The company has submitted an import permit application to the Australian Department of Health and is increasing its cannabis flower production, boasting over 5,000 kg in inventory and 30,000 plants in cultivation. The partnership, supported by their partner’s extensive experience, aims to establish recurring revenue streams in 2022, reflecting the company’s operational competence.

Allied Corp (OTCQB: ALID) has signed a dual-purpose agreement with Porter Ventures, LLC, focusing on legal products below 0.3% THC. The agreement begins with a supply of Colombian-produced flower, totaling 1000 kg monthly starting February 2022. Further, Porter will manufacture CBD flower cigarettes using Allied's product, aiming to enter the market for veterans. Allied's Colombian production facility is progressing well, and they are positioning themselves for future US cannabis market opportunities.